KI-0003

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKI-0003
Drug Alias Name19F MRI agent (Kereos)alpha-v/beta-3 integrin targeted 19F MRI agent (Kereos)KI-0003
ClassificationOther
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKereos Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKereos Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A